2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback
(Part 2 – PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies’ inputs on bioanalysis, biomarkers and immunogenicity)

Home > Science Hub > 2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback
(Part 2 – PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies’ inputs on bioanalysis, biomarkers and immunogenicity)
Back to the list

December 18, 2018

2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback
(Part 2 – PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies’ inputs on bioanalysis, biomarkers and immunogenicity)

Bioanalysis 2018; 10(23): 1897–1917.

You might also be interested by

Scientific Publications

Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes

February 1, 2021

Immune Monitoring

More info

Scientific Publications

Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease

December 15, 2020

Immune Monitoring

More info

Scientific Publications

Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses

December 15, 2020

Immune Monitoring

More info

Scientific Publications

Seroconversion stages COVID19 into distinct pathophysiological states

December 7, 2020

Immune Monitoring

More info